One of the major highlights of the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference is that invaluable networking opportunities can help clinicians elevate their own best practices.
Sharon Hesterlee, PhD
Advertisement
Sharon Hesterlee, PhD, is the chief research officer for the Muscular Dystrophy Association (MDA).
Articles by Sharon Hesterlee, PhD
Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Advertisement
Latest Updated Articles
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025Published: March 13th 2025 | Updated:
Building Community and Advancing Care at MDA 2025Published: March 24th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
The Growing ADC Landscape in TNBC Brings Questions, Opportunities: Rebecca Dent, MD, MSc
2
Brensocatib Reduced Symptom Burden, Neutrophil Serine Proteases Activity in Bronchiectasis
3
Climate Change Will Affect Pulmonary Health Across Intensive Care
4
Sexual Dysfunction From Cancer Is Widespread—and Many Don’t Know That Before Treatment, Data Show
5
